Jump Financial, LLC Harvard Bioscience Inc Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Oct 21, 2024
BUY
$4.19 - $6.16 $256,381 - $376,924
61,189 New
61,189 $335,000
Q2 2023

Aug 07, 2023
BUY
$4.19 - $6.16 $256,381 - $376,924
61,189 New
61,189 $335,000
Q2 2022

Aug 09, 2022
BUY
$3.28 - $6.42 $129,231 - $252,948
39,400 New
39,400 $142,000
Q3 2021

Nov 12, 2021
SELL
$6.98 - $8.47 $148,674 - $180,411
-21,300 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$5.44 - $8.4 $34,816 - $53,760
6,400 Added 42.95%
21,300 $177,000
Q1 2021

May 17, 2021
BUY
$3.91 - $6.99 $58,259 - $104,151
14,900 New
14,900 $81,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email